PHILADELPHIA -- A novel, plant-based oral estrogen improved metabolic profiles while also quelling menopause-related vasomotor symptoms, secondary outcomes from the phase III E4 Comfort I trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback